Remission in rheumatoid arthritis: wishful thinking or clinical reality?
about
Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.Remission in rheumatoid arthritis.Applying science in practice: the optimization of biological therapy in rheumatoid arthritis.Understanding emerging treatment paradigms in rheumatoid arthritisAspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activityRadiological damage in patients with rheumatoid arthritis on sustained remission.Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.Issues in the design of new clinical trials for rheumatoid arthritis therapeutics.Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials.Rheumatoid arthritis disease measurement: a new old idea.The problem of choice: current biologic agents and future prospects in RA.Selected cytokine pathways in rheumatoid arthritis.Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss.Potential of the HAQ score as clinical indicator suggesting comprehensive multidisciplinary assessments: the Swedish TIRA cohort 8 years after diagnosis of RA.Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments
P2860
Q33523412-44AA8062-251B-4584-97F9-B6E9A7AA4135Q33747197-BEC95E32-EB85-4C4B-B809-99A984C79270Q34081946-6A68D845-562E-4986-83BA-7460C47062DCQ34613898-75892AAD-E7AE-4505-A0D9-68152B3E8908Q35070450-67FC3780-D9FB-4630-8F60-0FF20A4416A2Q35605553-AD17BD75-9B9B-4BCB-B4A7-EEC446830E90Q35759974-2FEED36F-671E-4DD6-A792-D56C7CA8767CQ36104458-7A195FF9-DBA7-48FD-942B-467A0224E54BQ36416335-4668C89C-272E-4846-BB08-25957F7526FDQ37335856-40E1E798-519D-4495-A358-4485E556AD46Q37358239-B863962E-A71A-4D53-8C2F-0E1289E84392Q37690646-7DF39C59-48C1-4B88-B67E-69FE1428F76CQ38065766-DD6639AC-BE8B-4049-AEF0-428B7F98D504Q38082588-1CF049C2-38DC-4C1A-B8B9-DF35059FCDCDQ38755912-5CA6D9F1-DC36-4FB6-B789-DA92BE227438Q44326255-8B3F1900-D4CE-4456-BFB3-BB5763BE7D24Q46853695-2796A624-F146-41FD-B8CC-A9475FC123DDQ51176047-A43E3090-C161-4D27-9D09-4F513D3DBA8DQ56802112-B24600A3-77E4-4853-8E73-DA8728A95704
P2860
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@ast
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@en
type
label
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@ast
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@en
prefLabel
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@ast
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@en
P1476
Remission in rheumatoid arthritis: wishful thinking or clinical reality?
@en
P2093
Carlos A Sesin
Clifton O Bingham
P304
P356
10.1016/J.SEMARTHRIT.2005.06.003
P577
2005-12-01T00:00:00Z